CD14highCD16+ rather than CD14lowCD16+ monocytes correlate with disease progression in chronic HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 5, 2009, Pages 553-559

  Han, Junyan ^a,b   Wang, Beibei ^a,b   Han, Ning ^b   Zhao, Yan ^c   Song, Chuan ^a   Feng, Xin ^a   Mao, Yu ^a   Zhang, Fujie ^b,c   Zhao, Hongxin ^b   Zeng, Hui ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

CD16; HAART; HIV AIDS; Innate immunity; Monocytes; Pathogenesis

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD64 ANTIGEN; HLA DR ANTIGEN; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FC RECEPTOR;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; VIRUS LOAD; CROSS-SECTIONAL STUDY; IMMUNOLOGY; LEUKOCYTE COUNT; LONGITUDINAL STUDY; METABOLISM;

ANTI-HIV AGENTS; ANTIGENS, CD14; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MONOCYTES; RECEPTORS, IGG;

EID: 73349143027     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c1d4fe     Document Type: Article

References (36)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953-964.
2. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988;167:1428-1441.
3. Orenstein JM, Meltzer MS, Phipps T, et al. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human mono-cytes: an ultrastructural study. J Virol. 1988;62:2578-2586.
4. Perno CF, Svicher V, Schols D, et al. Therapeutic strategies towards HIV-1 infection in macrophages. Antiviral Res. 2006;71:293-300.
5. Bagnarelli P, Valenza A, Menzo S, et al. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol. 1996;70:7603-7613.
6. Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem. 2002;9:1893-1903.
7. Cassol E, Alfano M, Biswas P, et al. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol. 2006;80:1018-1030.
8. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006;211:609-618.
9. Whitelaw DM. Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet. 1972;5:311-317.
10. Zhu T. HIV-1 in peripheral blood monocytes: an underrated viral source. J Antimicrob Chemother. 2002;50:309-311.
11. Strauss-Ayali D, Conrad SM, Mosser DM. Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol. 2007;82: 244-252.
12. Ziegler-Heitbrock HW, Passlick B, Flieger D. The monoclonal anti-monocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma. 1988;7:521-527.
13. Ziegler-Heitbrock HW, Fingerle G, Strobel M, et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol. 1993;23:2053-2058.
14. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989;74:2527-2534.
15. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007;178:6581-6589.
16. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol. 1998;72:830-836.
17. Nockher WA, Bergmann L, Scherberich JE. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol. 1994;98:369-374.
18. Thieblemont N, Weiss L, Sadeghi HM, et al. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol. 1995;25:3418-3424.
19. Ancuta P, Autissier P, Wurcel A, et al. CD16+ monocyte-derived macrophages activate resting T cells for HIV infection by producing CCR3 and CCR4 ligands. J Immunol. 2006;176:5760-5771.
20. Grage-Griebenow E, Flad HD, Ernst M, et al. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology. 2000;202:42-50.
21. Grage-Griebenow E, Zawatzky R, Kahlert H, et al. Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur J Immunol. 2001;31:48-56.
22. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol. 2001;69:11-20.
23. Grage-Griebenow E, Flad HD, Ernst M. Fc gamma receptor I (CD64)-negative human monocytes are potent accessory cells in viral antigen-induced T cell activation and exhibit high IFN-alpha-producing capacity. J Leukoc Biol. 1996;60:389-396.
24. Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol. 1994;153:4016-4028.
25. Smith KA, Jacobson EL, Sohn T, et al. In vivo assessment of antiviral reactivity in chronic HIV infection. HIV Clin Trials. 2000;1:16-22.
26. Stevenson M. HIV-1 pathogenesis. Nat Med. 2003;9:853-860.
27. Moanna A, Dunham R, Paiardini M, et al. CD4+ T-cell depletion in HIV infection: killed by friendly fire? Curr HIV/AIDS Rep. 2005;2:16-23.
28. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol. 2008;126:235-242.
29. Ancuta P, Kunstman KJ, Autissier P, et al. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology. 2006;344:267-276.
30. Ziegler-Heitbrock HW. Definition of human blood monocytes. J Leukoc Biol. 2000;67:603-606.
31. Ziegler-Heitbrock HW, Strobel M, Kieper D, et al. Differential expression of cytokines in human blood monocyte subpopulations. Blood. 1992;79: 503-511.
32. Weber C, Belge KU, von HP, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol. 2000;67:699-704.
33. Fingerle G, Pforte A, Passlick B, et al. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993;82: 3170-3176.
34. Skrzeczynska J, Kobylarz K, Hartwich Z, et al. CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol. 2002;55:629-638.
35. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
36. Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol. 2003;74:635-641.